Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CUR > SEC Filings for CUR > Form 8-K on 21-Sep-2016All Recent SEC Filings

Show all filings for NEURALSTEM, INC.

Form 8-K for NEURALSTEM, INC.


21-Sep-2016

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events.

On September 21, 2016, Neuralstem, Inc. (the "Company") announced that it has reached over 50% enrollment in its Phase 2 clinical trial evaluating NSI-189, a novel neurogenic small molecule, for the treatment of major depressive disorder. A copy of the press release is attached to this report as Exhibit 99.01.



Item 9.01. Financial Statements and Exhibits.

Exhibit No. Description

99.01 Press Release Dated September 21, 2016


  Add CUR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CUR - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.